Viyash Scientific Overview

  • Year Founded
  • 1985

Year Founded

  • Status
  • Public

  • Employees
  • 4,131

Employees

  • Stock Symbol
  • 512529

Stock Symbol

  • Investments
  • 8

  • Share Price
  • $2.50
  • (As of Friday Closing)

Viyash Scientific General Information

Description

Viyash Scientific Ltd is engaged in the business of pharmaceuticals. The Company manufactures Active Pharmaceutical Ingredients (APIs), intermediates, finished formulations, and provides research and testing activities. It offers a comprehensive portfolio of APIs, intermediates, and formulations for human and animal health to serve diverse therapeutic needs. Its human API portfolio focuses on complex and niche molecules across key therapeutic areas, including potent segments such as oncology and immunology. The Company operates in the pharmaceuticals business and serves India, the USA, Spain and the Rest of the World, with maximum revenue generated from India.

Contact Information

Website
www.viyash.com
Formerly Known As
PI Drugs and Pharmaceuticals, Sequent Scientific
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Corporate Office
  • Plot Number 290, Srivaili's Corporate
  • Road Number 6, Madhapur
  • Hyderabad, Telangana 500033
  • India
+91 040
Primary Industry
Other Commercial Products
Stock Exchange
BOM
Vertical(s)
Corporate Office
  • Plot Number 290, Srivaili's Corporate
  • Road Number 6, Madhapur
  • Hyderabad, Telangana 500033
  • India
+91 040

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Viyash Scientific Stock Performance

As of 20-Nov-2026, Viyash Scientific’s stock price is $2.50. Its current market cap is $1.1B with 442M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.50 $2.52 $1.90 - $3.13 $1.1B 442M 355K $0.06

Viyash Scientific Financials Summary

As of 30-Sep-2026, Viyash Scientific has a trailing 12-month revenue of $400M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 1,127,499 895,853 436,968 398,992
Revenue 400,422 379,903 350,461 165,040
EBITDA 76,784 72,109 38,363 6,359
Net Income 25,085 20,063 2,746 (4,333)
Total Assets 534,201 490,542 483,084 184,713
Total Debt 60,821 51,907 76,491 58,481
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Viyash Scientific Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Viyash Scientific‘s full profile, request access.

Request a free trial

Viyash Scientific Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Viyash Scientific Ltd is engaged in the business of pharmaceuticals. The Company manufactures Active Pharmaceutical Ingr
Other Commercial Products
Hyderabad, India
4,131 As of 2026

Teaneck, NJ
 

Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Viyash Scientific Competitors (5)

One of Viyash Scientific’s 5 competitors is Phibro Animal Health, a Formerly PE-Backed company based in Teaneck, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Phibro Animal Health Formerly PE-Backed Teaneck, NJ
Ashish Life Science Venture Capital-Backed Mumbai, India
Mallinckrodt Pharmaceuticals Formerly PE-Backed Dublin, Ireland
Pil-psychotropics India Corporation Faridabad, India
Glenmark Pharmaceuticals Corporation Mumbai, India
You’re viewing 5 of 5 competitors. Get the full list »

Viyash Scientific Patents

Viyash Scientific Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018109781-A1 A process for the preparation of firocoxib Inactive 13-Dec-2016
US-20140100385-A1 Process for preparation of succinylcholine chloride Inactive 08-Oct-2012
WO-2013065064-A1 A process for preparation of l-(6-methylpyridin-3-yl)-2-[4-(meth.ylsulfonyi)phenyl]ethanone field of invention Inactive 31-Oct-2011
WO-2013021398-A2 A process for preparation of mivacurium chloride Inactive 05-Aug-2011
WO-2013021398-A3 A process for preparation of mivacurium chloride Inactive 05-Aug-2011 C07D217/20
To view Viyash Scientific’s complete patent history, request access »

Viyash Scientific Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Viyash Scientific Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Viyash Scientific‘s full profile, request access.

Request a free trial

Viyash Scientific Investments & Acquisitions (8)

Viyash Scientific’s most recent deal was a Merger/Acquisition with Viyash Life Sciences. The deal was made on 21-Jan-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Viyash Life Sciences 21-Jan-2025 Merger/Acquisition Pharmaceuticals
Vindhya Pharma 01-Sep-2019 Merger/Acquisition Distributors/Wholesale
Solara Active Pharma Sciences (EU-GMP API facility located at Mahad, Maharashtra) 01-Aug-2018 Corporate Asset Purchase Buildings and Property
Naari Pharma India 01-Jan-2016 Merger/Acquisition Pharmaceuticals
Alivira Animal Health 31-Mar-2015 Secondary Transaction - Private Other Pharmaceuticals and Biotechnology
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Viyash Scientific ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Viyash Scientific’s complete esg history, request access »

Viyash Scientific Exits (1)

Viyash Scientific’s most recent exit was on 01-Jan-2016 from Naari Pharma India. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Naari Pharma India 01-Jan-2016 Completed
To view Viyash Scientific’s complete exits history, request access »

Viyash Scientific Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Viyash Life Sciences Hyderabad, India 2019
Alivira Animal Health Mumbai, India 2013
SeQuent Scientific (Pharmaceutical Ingredient Unit in Thane) Thane, India

Viyash Scientific FAQs

  • When was Viyash Scientific founded?

    Viyash Scientific was founded in 1985.

  • Where is Viyash Scientific headquartered?

    Viyash Scientific is headquartered in Hyderabad, India.

  • What is the size of Viyash Scientific?

    Viyash Scientific has 4,131 total employees.

  • What industry is Viyash Scientific in?

    Viyash Scientific’s primary industry is Other Commercial Products.

  • Is Viyash Scientific a private or public company?

    Viyash Scientific is a Public company.

  • What is Viyash Scientific’s stock symbol?

    The ticker symbol for Viyash Scientific is 512529.

  • What is the current stock price of Viyash Scientific?

    As of 20-Nov-2026 the stock price of Viyash Scientific is $2.50.

  • What is the current market cap of Viyash Scientific?

    The current market capitalization of Viyash Scientific is $1.1B.

  • What is Viyash Scientific’s current revenue?

    The trailing twelve month revenue for Viyash Scientific is $400M.

  • Who are Viyash Scientific’s competitors?

    Phibro Animal Health, Ashish Life Science, Mallinckrodt Pharmaceuticals, Pil-psychotropics India, and Glenmark Pharmaceuticals are competitors of Viyash Scientific.

  • What is Viyash Scientific’s annual earnings per share (EPS)?

    Viyash Scientific’s EPS for 12 months was $0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process